Aims/objectives: To explore the variation of the predicted HbA1c in the Free Style Libre (FSL) flash glucose monitoring from the simultaneous measured laboratory HbA1c (IFCC) value.

Methods: We included all patients (n=114) with adequate data on FSL download who also had HbA1c estimation in the biochemistry laboratory as a part of follow-up review after FSL initiation for glycaemia management in diabetes. The date of measured HbA1c estimation was used in the FSL download to obtain a predicted HbA1c (2 months data download). The difference between the measured HbA1c and predicted HbA1c was calculated to obtain the variation between the two.

Results: The measured HbA1c prior to and post FSL initiation were 68.2±15.1 and 59.9±1.2 mmol/mol respectively, i.e the HbA1c improved by mean 8.3 mmol/mol (std. error 0.99) (P<0.001, paired sample t-test). The mean time duration between the pre and follow-up HbA1c estimations was 5.3±1.9 months. The predicted HbA1c on FSL download at follow-up was 61.8±10.1 mmol/mol. The correlation between the mean blood glucose on FSL and predicted HbA1c was significant (r=0.999) which would be expected as the predicted HbA1c was calculated from mean glucose in FSL. There was a significant correlation between measured HbA1c and predicted HbA1c was (r=0.86, P<0.001) The difference between the measured and predicted HbA1c was minus 2.3±7.2 mmol/mol with a wide range (minus 35 to +12 mmol/mol) with the difference being clinical significant (>10 mmol/mol difference) in 18.4% of the cohort.

Conclusions: This study confirms the variation of the measured HbA1c from that predicted from FSL flash glucose download data could be clinically significant in about a fifth of individuals. Variety of factors could contribute to such variation and may have clinical implications while managing individuals with diabetes.

Disclosure

J. Muthabathula: None. L. Grixti: None. T. Fletcher-Salt: None. A.U. Nayak: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.